This topic contains a solution. Click here to go to the answer

Author Question: When selecting a syringe-needle size for an IM injection, the age of the patient is of little ... (Read 33 times)

tatyanajohnson

  • Hero Member
  • *****
  • Posts: 569
When selecting a syringe-needle size for an IM injection, the age of the patient is of little consequence.
 
 Indicate whether the statement is true or false

Question 2

What immunizations will be recorded on a child's immunization record at age 15 months?
 
 DTaP(2), IPV(2), HIB(2), Hep B (2)
  DTaP(1), IPV(1), HIB(1), Hep B(1)
  DTaP(5), OPV(2), MMR(2) - if needed
  None of these answers
  DTaP(4), Polio(3), HIB(4), MMR(1)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bookworm410

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

False

Answer to Question 2

DTaP(4), Polio(3), HIB(4), MMR(1)

Rationale: DTaP(4), Polio(3), HIB(4), MMR(1) are given at 15 months.




tatyanajohnson

  • Member
  • Posts: 569
Reply 2 on: Jun 25, 2018
Great answer, keep it coming :)


LVPMS

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library